nonprofit logo

The Global Fund To Fight Aids Tuberculosis And Malaria

Learn about this cause: What are the reviews? Is it Legit? Do I like the mission? What is the CEO's salary?

EIN: 980380092 ✦ Designated as a 501(c)(3)

Shop smarter and support your favorite cause at the same time! With the Give Freely browser extension, you'll automatically save money with coupons, and partner stores will donate to your chosen charity - at no extra cost to you. Start giving back with a single click. It's safe, free, and spam-free, guaranteed!

Overview

What is The Global Fund To Fight Aids Tuberculosis And Malaria?

The Global Fund to Fight AIDS, Tuberculosis, and Malaria is a global nonprofit organization dedicated to ending the epidemics of HIV/AIDS, tuberculosis, and malaria to support the achievement of the Sustainable Development Goals set by the United Nations. By attracting, leveraging, and investing resources, the Global Fund plays a crucial role in preventing, treating, and caring for individuals affected by these diseases and strengthening health systems. Following the April 2020 board decision, the organization launched the COVID-19 Response Mechanism (C19RM) to provide grants to locally-developed programs and raised additional funding for COVID-19 emergency response. In 2022, the board extended the implementation of C19RM funds through 2025. The Global Fund received significant donor contributions in 2022, allocating over USD 2.3 billion to C19RM, making a significant impact in the ongoing global health crisis.


Official website here: www.theglobalfund.org

What are the reviews and ratings of this charity?

Charity Navigator rating: 86% (Three-Star out of Four Star rating)

The Global Fund To Fight Aids Tuberculosis And Malaria has achieved an 86% rating, indicating a strong performance in accountability and finance. This score is based solely on their Accountability & Finance metrics, which reflect the organization's commitment to maintaining a transparent and effective financial structure. The organization boasts a fully independent board and high scores in various areas, such as financial statement oversight and program expense ratio, demonstrating a solid governance framework.

One of the notable strengths of the Global Fund is its impressive program expense ratio of 99.02%, suggesting that the vast majority of its spending is directed towards its core mission of combating AIDS, tuberculosis, and malaria. Additionally, the organization has a robust set of policies in place to mitigate conflicts of interest and ensure accountability, highlighting its commitment to ethical practices.

However, the data indicates a material diversion of assets, which could be a point of concern for potential donors. While this does not significantly detract from the organization's overall performance, it is worth noting for those evaluating the risks associated with their contributions. Overall, the Global Fund demonstrates a strong operational framework, though transparency regarding asset management may need further clarification.


This AI summary has been generated from information found on Charity Navigator.

Is The Global Fund To Fight Aids Tuberculosis And Malaria legitimate?

The Global Fund To Fight Aids Tuberculosis And Malaria is a legitimate nonprofit organization registered as a 501(c)(3) entity. The Global Fund To Fight Aids Tuberculosis And Malaria submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.


Heare are some key statistics you may want to consider:

Executive Compensation: $7,948,152
Professional Fundraising Fees: $0
Other Salaries and Wages: $179,807,383

For more financial information, click here


Official website here: www.theglobalfund.org

What is the mission statement of The Global Fund To Fight Aids Tuberculosis And Malaria?

The Global Fund to Fight AIDS, Tuberculosis, and Malaria is a renowned organization dedicated to ending the epidemics of these three diseases and contributing to the achievement of the Sustainable Development Goals set by the United Nations. Its mission is to attract, leverage, and invest resources towards disease prevention, treatment, and care, as well as for health system strengthening. In response to the COVID-19 pandemic, the Global Fund launched an appeal and created the COVID-19 Response Mechanism (C19RM), which has been extended through 2025. In 2022, the organization received significant donor contributions, recognized in their Statement of Income, totaling USD 2.3 billion, allocated to C19RM in accordance with pledges. These funds support the Global Fund's ongoing efforts to combat these diseases and promote global health.


Official website here: www.theglobalfund.org

Who is the CEO of The Global Fund To Fight Aids Tuberculosis And Malaria?

Peter Sands is the Principal Officer of The Global Fund To Fight Aids Tuberculosis And Malaria.


Official website here: www.theglobalfund.org

What is the revenue of The Global Fund To Fight Aids Tuberculosis And Malaria?

The Global Fund To Fight Aids Tuberculosis And Malaria's revenue in 2022 was $6,964,263,943.


Official website here: www.theglobalfund.org

Who are the executives of The Global Fund To Fight Aids Tuberculosis And Malaria and what are their salaries?


Here are 56 key members and their salaries:


Joshua Tabah (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Javier Hourcade Bellocq (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Erika Castellanos (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Beatrijs Stikkers (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Robin Montgomery (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Dr Carolyn Gomes (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Susan Mochache (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Miso Pejkovic (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Dr Mohsen Asadi-Lari (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Dr Gabriela Fesus (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Anne-Claire Amprou (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Amb Stephanie Seydoux (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Tania Vorwerk (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Birgit Pickel (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Keichii Hara (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Alejandra Acua Navarro (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Dr Mirta Roses Periago (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Maire Matthews (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Kieran Daly (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Dr Rajendra Joshi (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Kunzang Wangdi (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Beth Arthy (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Amb John Nkengasong (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Dr Angeli Achrekar (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Dr Jean-Jacques Mbungani (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Prof Pascal Niamba (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Fiu Williame-Igara (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Sherwin Charles (Board Member)
  • Compensation: $0
  • Related: $0
  • Other: $0
Peter Alexander Sands (Executive Director)
  • Compensation: $410,843
  • Related: $0
  • Other: $95,798
Adda Faye (Chief Financial Officer)
  • Compensation: $359,232
  • Related: $0
  • Other: $78,843
Dr Donald Kaberuka (Chair)
  • Compensation: $40,000
  • Related: $0
  • Other: $0
Lady Roslyn Morauta (Vice-Chair)
  • Compensation: $30,000
  • Related: $0
  • Other: $0
Mark Eldon Edington (Head, Grant Management Division)
  • Compensation: $485,372
  • Related: $0
  • Other: $63,808
Maria Petrova Kirova (Head, Grant Management Department)
  • Compensation: $438,263
  • Related: $0
  • Other: $62,761
Michael Wainford Johnson (Chief Information Officer)
  • Compensation: $415,628
  • Related: $0
  • Other: $63,968
Michael David Byrne (Head, Tech Advisory & Partnerships)
  • Compensation: $396,707
  • Related: $0
  • Other: $57,865
Abigail Moreland (Head, Grant Management Department)
  • Compensation: $392,861
  • Related: $0
  • Other: $61,840
Harley Feldbaum (Head Strategy And Policy Hub)
  • Compensation: $387,162
  • Related: $0
  • Other: $57,226
Tracy Staines (Inspector General)
  • Compensation: $379,593
  • Related: $0
  • Other: $75,474
Rahul Singhal (Chief Risk Officer)
  • Compensation: $374,487
  • Related: $0
  • Other: $63,655
Francoise Vanni Chacin Solano (Head, External Relations And Comms)
  • Compensation: $355,501
  • Related: $0
  • Other: $67,653
Susie Rhee (General Counsel)
  • Compensation: $353,495
  • Related: $0
  • Other: $52,227
Annelise Hirschmann (Head, Grant Management Department)
  • Compensation: $320,452
  • Related: $0
  • Other: $46,646
Marijke Wijnroks (Chief Of Staff)
  • Compensation: $306,415
  • Related: $0
  • Other: $57,538
Urban Johannes Weber (Head, Grant Management Department)
  • Compensation: $279,312
  • Related: $0
  • Other: $57,213
Hui Yang (Chief Procurement Officer)
  • Compensation: $268,320
  • Related: $0
  • Other: $53,188
Linden Ridley Morrison (Head, Grant Management Department)
  • Compensation: $261,092
  • Related: $0
  • Other: $50,585
Caty Fall (Regional Manager, Central Africa)
  • Compensation: $259,073
  • Related: $0
  • Other: $65,824
Cynthia Simangela Mwase (Head, Grant Management Department)
  • Compensation: $245,704
  • Related: $0
  • Other: $56,532
Marasi Mwencha (Senior Manager, Supply Chain)
  • Compensation: $462,688
  • Related: $0
  • Other: $44,432
George Shakarishvili (Senior Manager, Strategy)
  • Compensation: $450,253
  • Related: $0
  • Other: $18,052
Scott Jay Filler (Head, Malaria Disease Advisor)
  • Compensation: $354,478
  • Related: $0
  • Other: $49,604
Noah Amador Zahrobsky (Senior Fund Portfolio Manager)
  • Compensation: $350,054
  • Related: $0
  • Other: $45,148
John Andrew Fairhurst (Head, Private Sector Engagements)
  • Compensation: $326,482
  • Related: $0
  • Other: $57,829
Mark Edward Saalfeld (Former Key Employee)
  • Compensation: $252,226
  • Related: $0
  • Other: $40,563
Fady Zeidan (Former Key Employee)
  • Compensation: $224,905
  • Related: $0
  • Other: $33,083


Official website here: www.theglobalfund.org

Where can I find the form 990 for The Global Fund To Fight Aids Tuberculosis And Malaria?

The Global Fund To Fight Aids Tuberculosis And Malaria's most recent form 990 was submitted in 2022 and can be accessed here.


Official website here: www.theglobalfund.org

Learn more at the official website: www.theglobalfund.org

Mission Statement of The Global Fund To Fight Aids Tuberculosis And Malaria

The Global Fund, a leading organization in the fight against HIV/Aids, Tuberculosis, and Malaria, is on a mission to attract, leverage, and invest resources to put an end to these epidemics and support the achievement of the Sustainable Development Goals established by the United Nations. This international partnership aims to provide grants to locally-developed programs aimed at the prevention, treatment, or care of these diseases and strengthening health systems.

In response to the COVID-19 pandemic, The Global Fund launched an appeal in April 2020 to raise additional funding for emergency response. This led to the creation of the COVID-19 Response Mechanism (C19RM), which was extended through further board decisions, enabling the implementation of C19RM funds through December 2025. During 2022, the organization recognized USD 2.3 billion in donor contributions towards C19RM in their Statement of Income.

The Global Fund's mission is to make a significant impact on global health by contributing funds to programs that address the needs of those affected by HIV/Aids, Tuberculosis, and Malaria. By working collaboratively with local communities and health systems, it invests resources to ensure that these diseases no longer pose a threat to the world's most vulnerable populations. The organization's commitment to ending these epidemics is unwavering, as it continues to strive for a healthier, more equitable world for all.

Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!

Impact




October, 2024

The Global Fund to Fight AIDS, Tuberculosis and Malaria has made a significant impact in global health, particularly in resource mobilization, epidemic control, and health system strengthening. By providing grants to locally-developed programs, it has facilitated prevention, treatment, and care initiatives aimed at combating HIV/AIDS, tuberculosis, and malaria.

In recent years, the Global Fund's efforts have expanded to address unexpected challenges, such as the COVID-19 pandemic. The establishment of the COVID-19 Response Mechanism (C19RM) allowed for timely funding to support countries in responding to the crisis while maintaining essential health services for combating the three primary diseases.

Financially, the Global Fund attracted substantial donor contributions, receiving USD 2.3 billion in 2022 alone to support its emergency response efforts. This influx of resources has been pivotal in extending the reach and effectiveness of healthcare interventions in vulnerable populations across the globe. The Global Fund’s commitment to the Sustainable Development Goals ensures that its initiatives are aligned with broader global health objectives, ultimately striving to end the epidemics of AIDS, tuberculosis, and malaria.




This information is meant to be a general summary of The Global Fund To Fight Aids Tuberculosis And Malaria. Please take the time to review official sources before making any decisions based upon the content provided here.


Financials

This financial information is from Propublica.

Revenue
$6,964,263,943 (2022)
Expenses
$5,054,461,601 (2022)
Efficiency

Other financial information:

This information is from the most recently submitted tax form from this organization, which was in 2022.

  • Investment Income: $97,516,626
  • Gross Receipts: $6,964,263,943

Assets and Liabilities:

  • Total Assets: $8,267,999,439
  • Total Liabilities: $3,660,917,671
  • Net Assets: $4,607,081,768

Want to help this charity, for free? You can click here to learn more about Give Freely

Organization Details

Founding Year

2002

Principal Officer

Peter Sands

NTEE Category

Code: H81 - Medical research

If you are a representative of The Global Fund To Fight Aids Tuberculosis And Malaria and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.